Cita APA

Martinez, B. K., Bunz, T. J., Eriksson, D., Meinecke, A., Sood, N. A., & Coleman, C. I. (2018). Effectiveness and safety of rivaroxaban vs. warfarin in patients with non‐valvular atrial fibrillation and heart failure. ESC Heart Fail.

Citación estilo Chicago

Martinez, Brandon K., Thomas J. Bunz, Daniel Eriksson, Anna‐Katharina Meinecke, Nitesh A. Sood, y Craig I. Coleman. "Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients With Non‐valvular Atrial Fibrillation and Heart Failure." ESC Heart Fail 2018.

Cita MLA

Martinez, Brandon K., et al. "Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients With Non‐valvular Atrial Fibrillation and Heart Failure." ESC Heart Fail 2018.